Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 10, Pages 4640-4651Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm300460c
Keywords
-
Categories
Funding
- University of Wisconsin-Milwaukee
- NIH [DA031090, DK58080]
- American Lebanese Syrian Associated Charities (ALSAC)
- St. Jude Children's Research Hospital
Ask authors/readers for more resources
The vitamin D receptor (VDR) is a nuclear hormone receptor that regulates cell proliferation, cell differentiation, and calcium homeostasis. The receptor is activated by vitamin D analogues that induce the disruption of VDR-corepressor binding and promote VDR-coactivator interactions. The interactions between VDR and coregulators are essential for VDR-mediated transcription. Small molecule inhibition of VDR-coregulator binding represents an alternative method to the traditional ligand-based approach in order to modulate the expression of VDR target genes. A high throughput fluorescence polarization screen that quantifies the inhibition of binding between VDR and a fluorescently labeled steroid receptor coactivator 2 peptide was applied to discover the new small molecule VDR-coactivator inhibitors, 3-indolylmethanamines. Structure-activity relationship studies with 3-indolylmethanamine analogues were used to determine their mode of VDR-binding and to produce the first VDR-selective and irreversible VDR-coactivator inhibitors with the ability to regulate the transcription of the human VDR target gene TRPV6.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available